Related Experiment Video
Updated: Mar 16, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.2K
Risk Factors for Priapism Readmission
Wilson Sui1, Ifeanyi C Onyeji1, Maxwell B James1
1Department of Urology, Columbia University Medical Center, New York, NY, USA.
The Journal of Sexual Medicine
|August 7, 2016
Summary
Nearly a quarter of men with priapism experienced recurrence within a year, often within 60 days. Key risk factors for priapism recurrence include sickle cell disease and drug abuse.
Area of Science:
- Urology
- Emergency Medicine
- Health Services Research
Background:
- Priapism is a serious urologic condition with a notable risk of recurrence.
- The frequency, timing, and risk factors associated with priapism recurrence require further characterization.
Purpose of the Study:
- To identify predictors of readmission for priapism.
Main Methods:
- Utilized the New York Statewide Planning and Research Cooperative System database (2005-2014).
- Analyzed 3,372 male patients presenting with priapism to emergency departments.
- Employed proportional hazards regression to determine risk factors for readmission within 12 months.
Main Results:
- 24% of patients were readmitted for recurrent priapism within one year.
- 68% of readmissions occurred within 60 days of the initial event.
- Significant risk factors for readmission included sickle cell disease, drug abuse/psychiatric disease, history of erectile dysfunction, and non-commercial insurance.
Conclusions:
- Recurrent priapism is common, with a substantial proportion of patients readmitted within a year.
- Early readmission (within 60 days) is frequent.
- Targeted strategies are needed to reduce priapism recurrence in high-risk populations.
Related Concept Videos
01:20Disorders of the Male Reproductive System
5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
01:23Peripheral Artery Disease V: Postoperative Nursing Management
515
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
515
01:27Pulmonary Embolism III: Nursing Management
614
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
614
01:28Cardiac Catheterization I: Pre-Procedure Overview
2.2K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.2K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
585
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
585
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
689
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
689